References
  1. Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, Cha YM, Clancy J, Deharo JC, Ellenbogen KA, Exner D, Hussein AA, Kennergren C, Krahn A, Lee R, Love CJ, Madden RA, Mazzetti HA, Moore JC, Parsonnet J, Patton KK, Rozner MA, Selzman KA, Shoda M, Srivathsan K, Strathmore NF, Swerdlow CD, Tompkins C, Wazni O. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503-e551.
  2. Baddour LM, Cha YM, Wilson WR. Clinical practice: infections of cardiovascular implantable electronic devices. N Engl J Med 2012;367:842-849.
  3. Sandoe JA, Barlow G, Chambers JB, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection: report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother 2015;70:325-359.
  4. Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med 2011;171:1821-1828.
  5. Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Rates of and factors associated with infection in 200909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation 2014;130:1037-1043.
  6. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007;115:2689-2696.
  7. Uslan DZ, Tleyjeh IM, Baddour LM, Friedman PA, Jenkins SM, St Sauver JL, Hayes DL. Temporal trends in permanent pacemaker implantation: a population- based study. Am Heart J 2008;155:896-903.
  8. Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J Interv Card Electrophysiol 2008;22:65-70.
  9. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17:767-777.
  10. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S; PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116:1349-1355.
  11. Reddy VY, Exner DV, Cantillon DJ, Doshi R, Bunch TJ, Tomassoni GF, Friedman PA, Estes NA 3rd, Ip J, Niazi I, Plunkitt K, Banker R, Porterfield J, Ip JE, Dukkipati SR; LEAD- LESS II Study Investigators: Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med 2015;373: 1125-1135.
  12. El-Chami MF, Al-Samadi F, Clementy N, Garweg C, Martinez-Sande JL, Piccini JP, Iacopino S, Lloyd M, Viñolas Prat X, Jacobsen MD, Ritter P, Johansen JB, Tondo C, Liu F, Fagan DH, Eakley AK, Roberts PR. Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. Heart Rhythm. 2018;15:1800-1807.
  13. Beurskens NEG, Tjong FVY, Dasselaar KJ, Kuijt WJ, Wilde AAM, Knops RE. Leadless pacemaker implantation after explantation of infected conventional pacemaker systems: A viable solution? Heart Rhythm. 2019;16:66-71.
  14. Kypta A, Blessberger H, Kammler J, Lambert T, Lichtenauer M, Brandstaetter W, Gabriel M, Steinwender C. Leadless Cardiac Pacemaker Implantation After Lead Extraction in Patients With Severe Device Infection. J Cardiovasc Electrophysiol. 2016;27:1067-1071.
  15. El-Chami MF, Johansen JB, Zaidi A, Faerestrand S, Reynolds D, Garcia-Seara J, Mansourati J, Pasquie JL, McElderry HT, Roberts PR, Soejima K, Stromberg K, Piccini JP. Leadless pacemaker implant in patients with pre-existing infections: Results from the Micra post approval registry. J Cardiovasc Electrophysiol. 2019;30:569-574.
  16. Zucchelli G, Barletta V, Della Tommasina V, Viani S, Parollo M, Mazzocchetti L, Cellamaro T, Paperini L, Di Cori A, De Lucia R, Segreti L, Soldati E, Bongiorni MG. Micra pacemaker implant after cardiac implantable electronic device extraction: feasibility and long-term outcomes. Europace. 2019;21:1229-1236.
  17. Chang D, Gabriels JK, Soo Kim B, Ismail H, Willner J, Beldner SJ, John RM, Epstein LM. Concomitant leadless pacemaker implantation and lead extraction during an active infection. J Cardiovasc Electrophysiol. 2020;31:860-867.
  18. Higuchi S, Shoda M, Saito S, Kanai M, Kataoka S, Yazaki K, Yagishita D, Ejima K, Hagiwara N. Safety and efficacy of transvenous lead extractions for noninfectious superfluous leads in a Japanese population: A single-center experience. Pacing Clin Electrophysiol. 2019;42:1517-1523.
  19. Wazni O, Epstein LM, Carrillo RG, Love C, Adler SW, Riggio DW, Karim SS, Bashir J, Greenspon AJ, DiMarco JP, Cooper JM, Onufer JR, Ellenbogen KA, Kutalek SP, Dentry-Mabry S, Ervin CM, Wilkoff BL. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol. 2010;55:579-586.
  20. Rodriguez Y, Garisto JD, Carrillo RG. Laser lead extraction in the octogenarian patient. Circ Arrhythm Electrophysiol. 2011;4:719-723.
  21. Pelargonio G, Narducci ML, Russo E, Casella M, Santangeli P, Canby R, Al-Ahmad A, Price LD, Di Biase L, Kwark CJ, Harwood M, Perna F, Bencardino G, Ierardi C, Trecarichi EM, Santelli E, Tumbarello M, Mohanty P, Bailey S, Burkhardt JD, Bellocci F, Natale A, Dello Russo A. Safety and effectiveness of transvenous lead extraction in octogenarians. J Cardiovasc Electrophysiol. 2012;23:1103-1108.
  22. Kutarski A, Polewczyk A, Boczar K, Ząbek A, Polewczyk M. Safety and effectiveness of transvenous lead extraction in elderly patients. Cardiol J. 2014;21:47-52.
  23. Fanari Z, Hammami S, Hammami MB, Hammami S, Shuraih M. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter
defibrillator on mitral and tricuspid regurgitation. J Electrocardiol. 2015;48:791-797.
  1. Kypta A, Blessberger H, Kammler J, Lichtenauer M, Lambert T, Silye R, Steinwender C: First autopsy description of changes 1 year after implantation of a leadless cardiac pacemaker: Unexpected ingrowth and severe chronic inflammation. Can J Cardiol 2015. pii: S0828- 282X:01699-2.
  2. Higuchi S, Shoda M, Satomi N, Iwanami Y, Yagishita D, Ejima K, Hagiwara N. Unique abdominal twiddler syndrome. J Arrhythm. 2019;35:142-144.